Actively Recruiting

Age: 13Years - 39Years
All Genders
NCT04262830

Cardiotoxicity Assessment Through Comprehensive Heart Imaging to Predict Heart Failure

Led by Hari Narayan · Updated on 2025-01-28

150

Participants Needed

1

Research Sites

574 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Anthracycline chemotherapies (e.g. doxorubicin, daunorubicin) are commonly given to treat pediatric cancer, and carry a risk of cardiotoxicity. Over the long term, children who receive these therapies have an increased risk of heart failure and early cardiovascular death. However, current strategies for identifying patients who are at risk prior to the development of significant changes in heart function are limited. This study will focus on imaging markers of cardiac injury and dysfunction with the goal of developing improved diagnostic tests and treatment strategies.

CONDITIONS

Official Title

Cardiotoxicity Assessment Through Comprehensive Heart Imaging to Predict Heart Failure

Who Can Participate

Age: 13Years - 39Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • English and Spanish speaking male and female subjects, ages 13-39 years old
  • Diagnosis of cancer at age <22 years
  • Previously treated with anthracycline therapy for cancer, with diagnosis at least two years prior.
Not Eligible

You will not qualify if you...

  • Contraindication to cardiac MRI, including non-MRI compatible metallic implants
  • Medical, psychiatric, or social disorders preventing completion of study testing or cardiac MRI without anesthesia
  • History of congenital heart disease more significant than patent foramen ovale or patent ductus arteriosus
  • Pregnancy at the time of enrollment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Rady Children's Hospital

San Diego, California, United States, 92123

Actively Recruiting

Loading map...

Research Team

H

Hari Narayan, MD

CONTACT

C

Cesar Vasquez

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here